Skip to content

Search

Search for:

CTTI

Clinical Trials Transformation Initiative

Join Our Newsletter

Who We Are
Our Work
Newsroom
Contact us

How Much Evidence Is Enough? Research Sponsor Experiences Seeking Regulatory Acceptance of Digital Health Technology-Derived Endpoints

News

Home - How Much Evidence Is Enough? Research Sponsor Experiences Seeking Regulatory Acceptance of Digital Health Technology-Derived Endpoints

Posted on June 8, 2023June 28, 2023 by kristi.geercken@duke.edu

How Much Evidence Is Enough? Research Sponsor Experiences Seeking Regulatory Acceptance of Digital Health Technology-Derived Endpoints

How Much Evidence Is Enough? Research Sponsor Experiences Seeking Regulatory Acceptance of Digital Health Technology-Derived Endpoints

This entry was posted in Developing Novel Endpoints, Publications, Related: Developing Novel Endpoints. Bookmark the permalink.

Post navigation

← Recording Now Available: CTTI Webinar Unveiling New Recommendations on Increasing Diversity in Clinical Trials

PEC Meeting Summary – May 2023 →

Who We Are
Our Work
Newsroom
Contact us

DISCLAIMER: CTTI encourages the use of all materials listed on this site in the pursuit of improving the clinical trials enterprise. Our recommendations, tools, meeting summaries, and more are available to the public for free. We do ask that you acknowledge the source whenever using or referencing CTTI materials. Read our Citation Policy.

Our Work Topics

Quality

Patient Engagement

Investigators and Sites

Digital Health Trials

Novel Clinical Trial Designs

Ethics and Human Research Protection

Log in

Privacy Statement

WordPress is a content management system and should not be used to upload any PHI as it is not an environment for which we exercise oversight, meaning you the author are responsible for the content you post. Please use this system accordingly.